Skip to main content

Table 1 Baseline characteristics of the patients

From: Effect of body mass index on pregnancy outcomes in young women with low-prognosis POSEIDON criteria after in vitro fertilization/intracytoplasmic sperm injection

 

Underweight

n = 518

Normal weight

n = 3447

Overweight

n = 1360

Obese

n = 656

P

Age (years)

30.13 ± 2.76

30.62 ± 2.62

30.36 ± 2.68

30.22 ± 2.78

 < 0.001a,d,e*

Infertility duration (years)

2.7 ± 1.88

2.96 ± 2.16

3.19 ± 2.15

3.82 ± 2.6

 < 0.001a,b,c,d,e,f

BMI(kg/m2)

17.58 ± 0.78

21.21 ± 1.48

25.64 ± 1.12

30.54 ± 2.27

 < 0.001a,b,c,d,e,f

AFC

8.6 ± 4.51

9.31 ± 5.04

10.35 ± 5.64

12.2 ± 6.48

 < 0.001a,b,c,d,e,f

AMH(ng/ml)

2.29 ± 2.2

2.42 ± 2.57

2.7 ± 2.63

2.9 ± 2.63

 < 0.001b,c,d,e

Basal serum FSH level (mIU/ml)

8.48 ± 4.17

7.51 ± 3.7

6.99 ± 7.27

6.4 ± 2.38

 < 0.001a,b,c,d,e,f

Basal serum E2 level (pmol/L)

175.05 ± 78.28

164.4 ± 86.21

166.91 ± 83.29

176.24 ± 83.03

0.001a,e,f

Basal serum LH level (mIU/ml)

5.24 ± 13.04

3.97 ± 2.9

3.8 ± 3.9

3.83 ± 3.09

 < 0.001a,b,c

Infertility cause n (%)

    

 < 0.001

Tubal

205 (39.6)

1333(38.7)

538 (39.6)

235 (35.8)

0.412

Male

149 (28.76)

995 (28.87)

370 (27.21)

156 (23.78)

0.054

Multiple

151 (29.2)

956 (27.7)

333 (24.5)

164 (25.0)

0.051

PCOS

13(2.5)

163(4.7)

119(8.8)

101(15.4)

 < 0.001b,c,d,e,f

  1. *: Data are shown as the number of patients (percentage) or mean ± SD. SD, standard deviation; BMI, body mass index; AMH, anti-Müllerian hormone; AFC, antral follicular count; PCOS, polycystic ovary syndrome; FSH, follicular stimulating hormone E2, estradiol; LH, luteinizing hormone. a P < 0.05, underweight vs. normal weight; b P < 0.05, underweight vs. overweight; c P < 0.05, underweight vs. obese; d P < 0.05, normal weight vs. overweight; e P < 0.05, normal weight vs. obese; f P < 0.05, overweight vs. obese